Literature DB >> 22856655

Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers.

C Pomara1, T Cassano, S D'Errico, S Bello, A D Romano, I Riezzo, G Serviddio.   

Abstract

Drug use is seen more as an individualistic behaviour and is therefore not readily conceived of from a population perspective. There is general recognition of several phases and degrees of drug abuse, from initiation and early-use patterns to long-term chronic use. Cocaine and its derivative "crack" cocaine provide an example of both the globalization of substance use and the cyclical nature of drug epidemics. Cocaine is a powerful CNS (Central Nervous System) stimulant but exerts its action in a several types of adverse health effects, including acute toxic effects (i.e. overdose, accidental injury and violence), dependence, cardiovascular disease, cirrhosis, bloodborne bacterial and viral infections, and mental disorders. Of interest, many people who use Cocaine will use also other drugs; therefore, ascribing adverse health effect to a certain drug might be difficult. Any mucous membrane can act as a port of entry for cocaine and the systemic effect is greatly influenced by the route and speed of administration. The effects of Cocaine mainly depend on the user's addiction, the dose received and the mode of assumption. Laws restricting the availability of cocaine saw a decrease in consumption in these countries until the 1960s. The number of cocaine users worldwide ranged from 14 million to 21 million (0.3-0.5% of the population aged 15-64 years). The largest market was North America, then western and central Europe and South America.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856655     DOI: 10.2174/092986712803988811

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  18 in total

1.  Cocaine-induced pulmonary changes: HRCT findings.

Authors:  Renata Rocha de Almeida; Gláucia Zanetti; Arthur Soares Souza; Luciana Soares de Souza; Jorge Luiz Pereira E Silva; Dante Luiz Escuissato; Klaus Loureiro Irion; Alexandre Dias Mançano; Luiz Felipe Nobre; Bruno Hochhegger; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2015 Jul-Aug       Impact factor: 2.624

Review 2.  Agonist Medications for the Treatment of Cocaine Use Disorder.

Authors:  S Stevens Negus; Jack Henningfield
Journal:  Neuropsychopharmacology       Date:  2014-12-11       Impact factor: 7.853

Review 3.  Effects of addictive drugs on adult neural stem/progenitor cells.

Authors:  Chi Xu; Horace H Loh; Ping-Yee Law
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

4.  Association between oral mucosal lesions and crack and cocaine addiction in men: a cross-sectional study.

Authors:  Patricia Ramos Cury; Nara Santos Araujo; Maria das Graças Alonso Oliveira; Jean Nunes Dos Santos
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-08       Impact factor: 4.223

5.  Dental health status in crack/cocaine-addicted men: a cross-sectional study.

Authors:  Patricia R Cury; Maria G A Oliveira; Katia Montanha de Andrade; Maíra D S de Freitas; Jean N Dos Santos
Journal:  Environ Sci Pollut Res Int       Date:  2017-01-24       Impact factor: 4.223

Review 6.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

7.  microRNA regulation related to the protective effects of environmental enrichment against cocaine-seeking behavior.

Authors:  Annika Vannan; Gregory L Powell; Michela Dell'Orco; Melissa A Wilson; Nora I Perrone-Bizzozero; Janet L Neisewander
Journal:  Drug Alcohol Depend       Date:  2021-02-16       Impact factor: 4.492

8.  NLRP3 Inflammasome Blockade Reduces Cocaine-Induced Microglial Activation and Neuroinflammation.

Authors:  Ernest T Chivero; Annadurai Thangaraj; Ashutosh Tripathi; Palsamy Periyasamy; Ming-Lei Guo; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

9.  Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure.

Authors:  Matthew L Banks; Blake A Hutsell; Bruce E Blough; Justin L Poklis; S Stevens Negus
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-24       Impact factor: 5.176

Review 10.  Diversity in Chemical Structures and Biological Properties of Plant Alkaloids.

Authors:  Sweta Bhambhani; Kirtikumar R Kondhare; Ashok P Giri
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.